Scrip Podcasts

Join us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five Must-Know Things.

This episode covers insights for the business week ended Oct. 23, 2026. This time—key expectations from ESMO meeting; next-generation antibody-drug conjugates; rising mid-cap stars; GSK's novel hepatitis B launch; and significant private company financings.

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/scrips-five-must-know-things-key-esmo-readouts-next-gen-adcs-and-mid-cap-winners-4HZXB64OXZASLBJAY6LE6D4DEY/

This and all our other podcasts are available on the Scrip channel on Apple Podcasts, and Spotify Podcasts and on TuneIn.

Any comments? [email protected]

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年10月23日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本周内容包括：欧洲肿瘤内科学会（ESMO）会议的关键预期；新一代抗体药物偶联物；冉冉升起的中盘股新星；葛兰素史克（GSK）新型乙肝药物的上市；以及私营企业的重大融资动态。

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/scrips-five-must-know-things-key-esmo-readouts-next-gen-adcs-and-mid-cap-winners-4HZXB64OXZASLBJAY6LE6D4DEY/

向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。

Feedback: [email protected]

Ahead of the awards presentation on Dec 2, the Scrip Awards podcast speaks to Mathai Mammen, CEO of Parabilis, one of the shortlisted companies for Biotech of The Year.

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年10月16日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本周内容包括：Tremfya从Stelara的余烬中崛起；辉瑞将成熟品牌作为试验田；中国科研力量在第三季度交易中大放异彩；Argenx在自身免疫领域取得进展与遭遇挫折；日本力图重振生物制药竞争力。

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-IZOIOAJVX5ERZMYRIYPGPLUVFA/

向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。

Feedback: [email protected]

Join us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five Must-Know Things.

This episode covers insights for the business week ended Oct. 16, 2026. This time—Tremfya rises from Stelara’s ashes; Pfizer uses mature brands as testbeds; Chinese science shines in Q3 deals; autoimmune win and setback for Argenx; and Japan looks to restore biopharma competitiveness.

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-IZOIOAJVX5ERZMYRIYPGPLUVFA/

This and all our other podcasts are available on the Scrip channel on Apple Podcasts, and Spotify Podcasts and on TuneIn.

Any comments? [email protected]

Join us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five Must-Know Things.

This episode covers insights for the business week ended Oct. 9, 2026. This time—China’s competitive threat; M&As cool off in Q3; new pneumococcal vaccine contender; strategy for Spanish biotechs; and Shionogi’s $2bn acquisition. 

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-ZCXOSRSNEBCARAW4DUWENVCPSQ/

This and all our other podcasts are available on the Scrip channel on Apple Podcasts, and Spotify Podcastsand on TuneIn.

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年10月9日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本周内容包括：中国带来的竞争威胁；第三季度并购活动降温；新型肺炎球菌疫苗竞争者；西班牙生物技术公司的战略；以及盐野义制药20亿美元的收购案。

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-ZCXOSRSNEBCARAW4DUWENVCPSQ/

向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。

Feedback: [email protected]

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年10月2日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本期要闻: 谁在引领今年的并购步伐；罗氏（Roche）的研发管线重整；湿性黄斑变性（wet AMD）市场的洗牌；默克公司（Merck & Co.）撤回I-DXd申报；以及默克将Recarbio从市场上撤回。

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-2AT2CA2SLFGNRJAGBHJAMN25F4/

向听众们简要更新一下：Scrip现在已在Spotify和Apple Podcasts上开设了专属播客频道。

Feedback: [email protected]

Audio roundup of selected biopharma industry content from Scrip over the business week ended Oct. 2, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.

This time—who’s setting the M&A pace this year; Roche’s pipeline reset; wet AMD market shakeup; Merck & Co. pulls I-DXd filing; and Merck withdraws Recarbio from the market. 

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-2AT2CA2SLFGNRJAGBHJAMN25F4/

 This and all our other podcasts are available on the new Scrip channel on Apple Podcasts, and Spotify Podcasts and on TuneIn.

Contact us on [email protected].